Just a little zap and temporary pores open. Inovio Biomedical (San Diego) is banking on this process, known as electroporation, to substantially change vaccine delivery. It has just unveiled a new clinical-grade, miniaturized device designed to deliver a variety of DNA vaccines, opening the door to push its healthy pipeline of new-style preventive and therapeutic vaccines into human trials. (Medical Device Daily) Read More
